HB Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
2,712
+303
| +13% | +$38.1K | ﹤0.01% | 873 |
|
|
2025
Q1 | $330K | Buy |
2,409
+820
| +52% | +$112K | ﹤0.01% | 908 |
|
|
2024
Q4 | $243K | Buy |
1,589
+213
| +15% | +$32.6K | ﹤0.01% | 886 |
|
|
2024
Q3 | $267K | Sell |
1,376
-607
| -31% | -$118K | ﹤0.01% | 785 |
|
|
2024
Q2 | $460K | Buy |
1,983
+338
| +21% | +$78.4K | 0.01% | 561 |
|
|
2024
Q1 | $355K | Buy |
1,645
+237
| +17% | +$51.1K | ﹤0.01% | 597 |
|
|
2023
Q4 | $364K | Sell |
1,408
-252
| -15% | -$65.2K | 0.01% | 540 |
|
|
2023
Q3 | $427K | Buy |
1,660
+194
| +13% | +$49.9K | 0.01% | 472 |
|
|
2023
Q2 | $418K | Buy |
1,466
+81
| +6% | +$23.1K | 0.01% | 461 |
|
|
2023
Q1 | $385K | Buy |
1,385
+154
| +13% | +$42.8K | 0.01% | 475 |
|
|
2022
Q4 | $341K | Sell |
1,231
-55
| -4% | -$15.2K | 0.01% | 487 |
|
|
2022
Q3 | $343K | Buy |
+1,286
| New | +$343K | 0.01% | 412 |
|